Department of Engineering / Profiles / Dr Christopher Proctor

Department of Engineering

Dr Christopher Proctor


Christopher Proctor

Research Associate in the Fabrication and Validation of Implantable Ion Pumps

Academic Division: Electrical Engineering

Telephone: TBC


Personal website


Research interests

Chris's research is focused on engineering devices and developing materials to enable a seamless connection between electronics and living tissue in order to address intractable disorders. On going project themes include:

Electrophoretic drug delivery: Targeted drug delivery can focus treatment on the region of the body affected by a given pathology thereby enhancing the effectiveness of the treatment while reducing side effects inherent in systemic treatments. Towards that end, we are leveraging the ion conductivity of polymers to develop implantable devices that can deliver drugs precisely when and where they are needed. We showed this to be a promising method for managing epileptic seizures. We are currently testing the efficacy of this approach for treating pathologies such as brain tumours and Parkinson’s disease.

Flexible devices for neural interfaces: We explore the application of organic electronic materials patterned onto flexible polymeric substrates in neural interfacing aiming to understand how the brain works and to develop new tools to address neurological disorders.

Research opportunities

Students and collaborators interested in Chris's research are invited to contact him to discuss opportunities.


Chris received a B.Sc. in Interdisciplinary Physics from the University of Michigan in 2008. Following two years as a general scientist at the U.S. Nuclear Regulatory Commission, he earned a Ph.D. in Materials from the University of California, Santa Barbara where he investigated loss mechanisms in organic photovoltaics (2015).

Subsequently, Chris was awarded a postdoctoral fellowship from Whitaker International to develop implantable bioelectronic devices for treating neurological disorders at the Ecole des Mines de St Etienne. He is now continuing this work as a Research Associate and Borysiewicz Biomedical Sciences Fellow at the University of Cambridge.